Exhibit 10.15


 


CONFIRMATION OF RESCISSION OF NOTE AMENDMENTS


 


On November 27, 2020 and February
10, 2021, 180 Life Corp., CannBioRex Pharma Ltd. and CannBioRex Pharma Corp., each director or indirect subsidiaries of 180 Life Sciences
Corp., a Delaware corporation (the “Companies”), entered into 18 Amendment to Loan Agreements with Sir Marc
Feldmann, as more fully described in Exhibit A (collectively, the “Note Amendments”).


 


The Note Amendments were entered
into in error, and by their execution of this Confirmation of Rescission of Note Amendments below, Sir Marc Feldmann and the Companies,
agree, confirm and acknowledge that:


 


		●	The Note Amendments were entered into error and did not reflect
the agreement of the parties thereto;



 


		●	Such Note Amendments are rescinded and terminated, effective
as of the applicable dates set forth under “Date of Amendment” on Exhibit A (the “Effective Date”,
as applicable); and



 


		●	The effect of this Confirmation of Rescission of Note Amendments
shall be as if such Note Amendments were never entered into by the parties, never effective and never binding, effective as of the Effective
Date (as applicable).



 


	 	 	180 Life
    Corp.
	 	 	 	 
	 	 	By:	/s/ James Woody 
	 	 	 	 
	 	 	Printed Name:	James Woody
	 	 	 	 
	 	 	Its:	CEO 180 Life Sciences
	 	 	 	 
	 	 	CannBioRex Pharma Ltd.
	 	 	 	 
	 	 	By:	/s/ Ozan Pamir
	 	 	 	 
	 	 	Printed Name:	Ozan Pamir
	 	 	 	 
	 	 	Its:	CFO 
	 	 	 	 
	 	 	CannBioRex Pharma Corp. 
	 	 	 	 
	 	 	By:	/s/ Ozan Pamir
	 	 	 	 
	 	 	Printed Name: 	Ozan Pamir
	 	 	 	 
	 	 	Its:	CFO
	 /s/ Marc Feldmann	 		 
	Sir Marc Feldmann	 		 



 




     


     


    

 


EXHIBIT A


 


	Number	 	Noteholder Name	 	Date of

 Amendment	 	Borrower	 	Currency	 	Amount	 	 	Date of Original Note
	1	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	GBP	 	 	60,000	 	 	10/20/2019
	2	 	Sir Marc Feldmann	 	2/10/2021	 	 CannBioRex Pharma Ltd.	 	GBP	 	 	5,198.18	 	 	2/28/2019
	3	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	40,000	 	 	10/29/2019
	4	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	10,000	 	 	10/29/2019
	5	 	Sir Marc Feldmann	 	2/10/2021	 	 CannBioRex Pharma Ltd.	 	GBP	 	 	15,029.78	 	 	11/27/2019
	6	 	Sir Marc Feldmann	 	2/10/2021	 	CannBioRex Pharma Corp.	 	CAD	 	 	10,000	 	 	12/11/2019
	7	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	137,381	 	 	1/20/2020
	8	 	Sir Marc Feldmann	 	2/10/2021	 	 CannBioRex Pharma Ltd.	 	GBP	 	 	5,193.18	 	 	1/30/2020
	9	 	Sir Marc Feldmann	 	2/10/2021	 	 CannBioRex Pharma Ltd.	 	GBP	 	 	14,111.43	 	 	2/28/2020
	10	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	1,871.75	 	 	4/2/2020
	11	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	1,563.75	 	 	4/2/2020
	12	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	12,905	 	 	4/13/2020
	13	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	7,889.75	 	 	5/30/2020
	14	 	Sir Marc Feldmann	 	11/27/2020	 	 CannBioRex Pharma Ltd.	 	GBP	 	 	6,712.31	 	 	8/26/2020
	15	 	Sir Marc Feldmann	 	2/10/2021	 	181 Life Corp.	 	GBP	 	 	5,833.33	 	 	4/28/2020
	16	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	GBP	 	 	5,193.18	 	 	10/30/2019
	17	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	USD	 	 	1,961	 	 	5/19/2020
	18	 	Sir Marc Feldmann	 	2/10/2021	 	180 Life Corp.	 	GBP	 	 	5,833.33	 	 	5/29/2020